Featured Research

from universities, journals, and other organizations

A natural boost for MRI scans

Date:
October 21, 2013
Source:
Ecole Polytechnique Fédérale de Lausanne
Summary:
Using an innocuous agent that is already naturally produced in the body, researchers have developed a breakthrough method that can make contrast-enhanced MRI safer and cheaper.

Magnetic resonance imaging (MRI) is a technique widely used in medicine to create images of internal organs such as the heart, the lungs, the liver and even the brain. Since its invention in 1977, MRI has become a staple of clinical radiology, used across the world to identify health problems in millions of patients worldwide. But despite its prominence, MRI suffers from low sensitivity, which can be improved by injecting patients with potentially toxic agents. Publishing in PNAS, researchers from EPFL have found a way to achieve high spatial and temporal resolution MRI using a safe compound that is naturally produced in the body.

MRI works by manipulating the alignment of the body's hydrogen atoms, which are susceptible to magnetic fields. Normally, our body's atoms spin around randomly, without any observable direction. During an MRI scan, a powerful magnet is used to generate a magnetic field that can be up to 40,000 times stronger than the Earth's. This causes approximately half the atoms to align towards the patient's head and the other half towards the feet.

The opposing alignment of the body's atoms cancels out much of the background 'noise', since for every atom lined up one way there is one lined up the opposite way. However, a few atoms per million (still a huge amount in total) line up in either direction without a cancelling counterpart. By reading out the energy levels of these atoms, the MRI computer can generate detailed images of the body, which can be central in diagnosing disease.

A well-known weakness of MRI is low sensitivity. This can be addressed with the use of hyperpolarization techniques, which involve injecting patients with substrates that contain a stable carbon isotope that is almost perfectly aligned with the machine's magnetic field. However, the preparation of these contrast agents requires the use of highly reactive chemicals called persistent radicals, which can be potentially toxic. Consequently, they have to also be filtered out prior to injecting the substrates and require additional pharmacological tests, all of which considerably reduce the MRI contrast, while posing a risk to the patient.

Researchers replace toxic chemicals with a natural substance

A research team led by Arnaud Comment developed a breakthrough solution to this problem. They found that high resolution in contrast-enhanced MRI can still be achieved with pyruvic acid, an organic chemical that occurs naturally in the body as a result of glucose breakdown, without the need of persistent radicals.

The scientists exposed frozen, pure pyruvic acid to ultraviolet light for an hour, which resulted in the generation of non-persistent radicals at a high concentration. The radicals automatically recombine to produce a solution only containing compounds that are naturally present in the body but in much lower concentrations. It was used to perform high-resolution MRI on a mouse brain. The resulting images showed detailed spatial and temporal resolution to the point of tracking the metabolism of pyruvic acid in the animal's brain.

The new hyperpolarization method opens a way to perform MRI with compounds that are not toxic, thus reducing or altogether eliminating associated health risks. In addition, because it does not require filtering or additional tests, the method will cut down on the time and cost of contrast-enhanced MRI protocols, thus improving the quality of the scans and diagnosis. The authors believe that the technique will be rapidly incorporated into the clinical setting and call it "a substantial step forward toward clinical radiology free of side effects."


Story Source:

The above story is based on materials provided by Ecole Polytechnique Fédérale de Lausanne. Note: Materials may be edited for content and length.


Journal Reference:

  1. Tim R. Eichhorn, Yuhei Takado, Najat Salameh, Andrea Capozzi, Tian Cheng, Jean-Noël Hyacinthe, Mor Mishkovsky, Christophe Roussel, and Arnaud Comment. Hyperpolarization without persistent radicals for in vivo real-time metabolic imaging. PNAS, October 2013

Cite This Page:

Ecole Polytechnique Fédérale de Lausanne. "A natural boost for MRI scans." ScienceDaily. ScienceDaily, 21 October 2013. <www.sciencedaily.com/releases/2013/10/131021153206.htm>.
Ecole Polytechnique Fédérale de Lausanne. (2013, October 21). A natural boost for MRI scans. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2013/10/131021153206.htm
Ecole Polytechnique Fédérale de Lausanne. "A natural boost for MRI scans." ScienceDaily. www.sciencedaily.com/releases/2013/10/131021153206.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Some Positive Ebola News: Outbreak 'Contained' In Nigeria

Newsy (Sep. 30, 2014) — The CDC says a new case of Ebola has not been reported in Nigeria for more than 21 days, leading to hopes the outbreak might be nearing its end. Video provided by Newsy
Powered by NewsLook.com
UN Ebola Mission Head: Immediate Action Is Crucial

UN Ebola Mission Head: Immediate Action Is Crucial

AFP (Sep. 30, 2014) — The newly appointed head of the United Nations Mission for Ebola Emergency Response (UNMEER), Anthony Banbury, outlines operations to tackle the virus. Duration: 00:39 Video provided by AFP
Powered by NewsLook.com
CDC Confirms First Case of Ebola in US

CDC Confirms First Case of Ebola in US

AP (Sep. 30, 2014) — The CDC has confirmed the first diagnosed case of Ebola in the United States. The patient is being treated at a Dallas hospital after traveling earlier this month from Liberia. (Sept. 30) Video provided by AP
Powered by NewsLook.com
New Breast Cancer Drug Extends Lives In Clinical Trial

New Breast Cancer Drug Extends Lives In Clinical Trial

Newsy (Sep. 30, 2014) — In a clinical trial, breast cancer patients lived an average of 15 months longer when they received new drug Perjeta along with Herceptin. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins